Riskpilot← Back to searchSign inGet full accessNORDIC BIOSCIENCE A/S
A/SActiveCVR 30799968Herlev Hovedgade 205Research and experimental development on natural sciences and engineering · NACE 7210Est. 2007196 employeeswww.nordicbioscience.com
Revenue 2024
DKK 324,9M
+37% vs 2023
EBITDA margin
29.9%
+193% vs 2023
Equity ratio
26.2%
Financial strength
Net profit 2024
DKK 78,4M
+133% vs 2023
| Revenue | DKK 324,9M | +37% |
| EBITDA | DKK 97,1M | +193% |
| Net profit | DKK 78,4M | +133% |
| Total assets | DKK 425,4M | +46% |
| Equity | DKK 111,3M | +81% |
| Employees | 196 | — |
Legal name
NORDIC BIOSCIENCE A/S
CVR number
30799968
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
13. august 2007
Share capital
DKK 10.000.000
Employees
196 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to medlemmer af bestyrelsen i forening, af et medlem af bestyrelsen og en direktør i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed indenfor bioteknologi og anden dermed i forbindelse stående virksomhed, herunder at eje datterselskaber og kapitalandele i forbindelse hermed.
Address
Herlev Hovedgade 205
Phone
+4544525252
Email
info@nordicbio.com
Website
www.nordicbioscience.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.791 | 15.783 | 21.530 | 28.424 | 113.881 | 161.999 | 231.587 | 216.227 | 254.960 | 271.014 | 313.570 | 236.409 | 324.920 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -63.526 | -65.956 | -0 | -0 | -0 | -119.429 | -145.710 |
| EBITDA | -4.723 | 1.739 | 10.689 | 8.938 | 41.872 | 77.846 | 122.477 | 99.949 | 114.038 | 128.715 | 139.790 | 33.096 | 97.108 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -3.870 | -4.256 | -5.110 | -5.669 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -4.723 | 1.739 | 10.689 | 8.938 | 38.002 | 73.590 | 117.367 | 94.280 | 114.038 | 128.715 | 139.790 | 33.096 | 97.108 |
| Net financials | -51.867 | -3.464 | -6.420 | -15.796 | -9.203 | -13.770 | -12.712 | 1.235 | -1.882 | -1.225 | -1.682 | 9.912 | 4.492 |
| Profit before tax | -50.840 | -1.725 | 4.269 | -6.858 | 28.798 | 59.820 | 104.655 | 95.515 | 112.156 | 127.490 | 138.108 | 43.008 | 101.600 |
| Tax | 2.875 | 4.943 | 3.183 | 565 | 9.169 | 8.752 | 28.320 | 21.223 | 18.802 | 22.694 | 24.875 | 9.344 | 23.212 |
| Net profit | -53.715 | -6.667 | 1.087 | -7.423 | 19.630 | 51.068 | 76.335 | 74.292 | 93.354 | 104.796 | 113.234 | 33.664 | 78.388 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 188.864 | 221.179 | 172.954 | 190.323 | 182.850 | 189.593 | 227.614 | 265.598 | 255.699 | 265.898 | 271.867 | 291.155 | 425.370 |
| Equity | 10.222 | 14.130 | 15.172 | 7.640 | 27.368 | 78.446 | 104.801 | 120.093 | 113.378 | 117.731 | 71.667 | 61.597 | 111.251 |
| Long-term debt | 9.973 | 14.231 | 20.632 | 19.135 | 17.926 | 16.749 | 15.559 | 54.165 | 54.829 | 45.351 | 42.198 | 39.829 | 39.440 |
| Short-term debt | 168.669 | 192.818 | 137.150 | 163.549 | 137.556 | 94.398 | 107.254 | 90.955 | 86.897 | 101.995 | 155.053 | 186.470 | 273.455 |
| Total debt | 178.641 | 207.049 | 157.783 | 182.683 | 155.482 | 111.147 | 122.813 | 145.120 | 141.726 | 147.346 | 197.251 | 226.299 | 312.895 |
EBITDA margin
29.9%
This company
15.8%
Market median
+89% vs market
20122024
Equity ratio
26.2%
This company
38.2%
Market median
-31% vs market
20122024
Return on equity
70.5%
This company
18.4%
Market median
+283% vs market
20122024
Net profit margin
24.1%
This company
8.1%
Market median
+198% vs market
20122024
Asset turnover
0.76×
This company
1.12×
Market median
-32% vs market
20122024
Debt / equity
2.82×
This company
0.62×
Market median
-355% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PD Management | Management | 2008 | — | — |
MA Management | Management | 2010 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2007 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
NORDIC BIOSCIENCE HOLDING A/S | Company | 100.0% | 100.0% | 2007 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nordic Life Science Consulting ApS
NORDIC BIOSCIENCE A/S Board members of NORDIC BIOSCIENCE A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Degnboel Thostrup | Management | 0 companies |
| Morten Asser Karsdal | Management | 0 companies |
| Thomas Nielsen | Board of Directors | 0 companies |
| Bente Juel Christiansen | Board of Directors | 0 companies |
| Claus Henrik Christiansen | Board of Directors | 0 companies |